Quality is our promise.

Call us today! 1-888-502-2050

1

May
2015
PRESS
RELEASE

KRS Global Reveals That It Has Produced Sterile Injectables in Closed Vial System Since Q3 of 2014

Boca Raton, FL: KRS Global Biotechnology (KRS-GBT), FDA Registered Human Drug Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to reveal closed-system automation already in place. FOR IMMEDIATE RELEASE Colanar Modular Syringe, Vial and Cartridge Filling System – FSM Boca Raton, FL., November 18, 2014 – […]

23

April
2015
PRESS
RELEASE

KRS Global Biotechnology, Inc. Announces FDA Registration and Inspection of Becoming an Outsourcing Facility (via section 503B); Compounding Quality Act

KRS Global Biotechnology, Inc. a specialty pharmacy preparing drugs no longer commercially available or in short supply announces today that they have become a registered Outsourcing Facility under the new Compounding Quality Act. BOCA RATON, FL., 14th April, 2014 – KRS Global Biotechnology, Inc. is pleased to announce that it has been recognized as a […]